Authors
Latest:
Direct and Indirect Cost Burden of Chronic Hepatitis CAn estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Latest:
Epilepsy: Calculating Risks of Driving Post-SeizureLegal restrictions on how long patients who've had a seizure must wait before resuming driving a motor vehicle vary widely by state in the U.S.
Latest:
Cancer Pain Treatment Remains a ChallengeSome patients are hesitant to use this class of drugs because of the stigma of potential addiction.
Latest:
Zooming Through the Pandemic: NSU Virtual AMCP Student ChapterThere are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Latest:
The Legal Rights of Transgender Patients Under the Affordable Care ActTransgender patients face many barriers in the health care system, one of which is the lack of clarity on their rights as patients.
Latest:
Work Productivity Associated With Treated Versus Never-Treated Overactive Bladder SymptomsOveractive bladder symptoms can impair work productivity, especially among untreated adults, with work productivity impairment costs nearly twice as high for never-treated versus treated subjects.
Latest:
Reimbursement Cuts Will Undermine PharmacyMr. Eckel is professor and director of the Office of Practice Development and Education at the School of Pharmacy, University of North Carolina at Chapel Hill.
Latest:
Health Systems’ Role in Specialty Pharmacy Moves Into Focus at AsembiaCohesion among key stakeholders, which will lead to an evolution in care, is clearly on the rise, and the growth of those relationships will only benefit patients in the end.
Latest:
Assessing the Association Between Medication Adherence and Glycemic ControlAmong a population of adult patients with type 2 diabetes, adherence to oral hypoglycemic medications is independently associated with poor glycemic control, even after adjusting for patient-level covariates.
Latest:
Impact of Drug Therapy Duration in Patients With Hepatitis CAdherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.
Latest:
Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and CostsReal-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.
Latest:
Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis TreatmentThe authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.
Latest:
Chronic Weight Management: New MedicationsTwo new medications have recently been approved to help patients lose weight: lorcaserin and phentermine and topiramate extended-release.
Latest:
Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing BarriersThis paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Latest:
Hemophilia and Managed Care: Partnering to Achieve Cost-Effective CareExploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Latest:
Utilizing Companion Diagnostics to Drive Clinical DecisionsA shift toward precision oncology has individual treatment plans being created for improving patient outcomes.
Latest:
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic ArthritisFor patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Latest:
Viability of a Dose Optimization Program Within a Specialty PharmacyDose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.
Latest:
FDA to Review NDA for Metastatic Prostate Cancer DrugEnzalutamide (Xtandi) capsules treats patients with metastatic castration-resistant prostate cancer.
Latest:
10 Strategies for Minimizing Dispensing ErrorsDispensing errors can be costly for the pharmacist as well as potentially dangerous for the patient. Pharmacists can take simple steps to help eliminate this problem.
Latest:
Why Pharmacists Should Recommend Asthma SpacersPharmacists should recommend asthma spacers to patients taking inhaler therapy for uncontrolled asthma because the devices can help improve hand-breath coordination while reducing side effects of inhaled medication.
Latest:
Together Beyond COVID-19: A Look at the Future of the Pharmaceutical IndustryIn a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.
Latest:
Bevacizumab Intravitreal Injection Intraocular Pressure Found Safe, TolerableIncrease in intraocular pressure found to be tolerable to the corneal endothelium and safe for treating central serous chorioretinopathy or diabetic macular edema.
Latest:
Smoking Cessation: Overcoming Nicotine DependencePharmacists can learn about the available interventions for smoking cessation.
Latest:
Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine DevicesThis analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.
